WSJ Your Money Briefing What’s News in Markets: Wegovy Pill, Salesforce AI Woes, BlackRock Record
12 snips
Jan 17, 2026 Investors are buzzing over Novo Nordisk's Wegovy pill launch, which has led to significant stock gains. Meanwhile, Salesforce faces declining sentiment as concerns grow about the software sector. BlackRock has hit a staggering $14 trillion in assets, driven by strong inflows and market performance. The podcast dives into these major stock movements and the underlying news shaping the markets.
AI Snips
Chapters
Transcript
Episode notes
Market Calm Amid Powell Investigation
- Markets stayed calm despite political turmoil around Fed Chair Jerome Powell's investigation.
- Investors feared that threats to Fed independence could fuel inflation and unsettle markets.
Wegovy Pill's Strong Early Uptake
- Novo Nordisk's Wegovy pill saw a strong early U.S. start with over 4,000 prescriptions in one week.
- The U.K. approved a higher dose and the company awaits U.S. and E.U. approvals for that dose.
AI Threatens Traditional Software Moats
- Rapid AI advances are unnerving investors in large software companies without any specific bad earnings news.
- Fears focus on AI doing coding and enabling companies to build or replace enterprise software internally.